Article
Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
Talanta - 1 Jul 2023
Stridfeldt Fredrik, Cavallaro Sara, Hååg Petra, Lewensohn Rolf, Linnros Jan, Viktorsson Kristina, Dev Apurba
Abstract excerpt
Precision cancer medicine has changed the treatment landscape of non-small cell lung cancer (NSCLC) as illustrated by the introduction of tyrosine kinase inhibitors (TKIs) towards mutated epidermal growth factor receptor (EGFR). However, as responses to EGFR-TKIs are heterogenous among NSCLC patients, there is a need for ways to early monitor changes in treatment response in a non-invasive way e.g., in patient's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
